Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.
El-Gamal MI, Mewafi NH, Abdelmotteleb NE, Emara MA, Tarazi H, Sbenati RM, Madkour MM, Zaraei SO, Shahin AI, Anbar HS. El-Gamal MI, et al. Among authors: zaraei so. Molecules. 2021 Dec 5;26(23):7376. doi: 10.3390/molecules26237376. Molecules. 2021. PMID: 34885957 Free PMC article. Review.
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
El-Gamal MI, Ullah S, Zaraei SO, Jalil S, Zaib S, Zaher DM, Omar HA, Anbar HS, Pelletier J, Sévigny J, Iqbal J. El-Gamal MI, et al. Among authors: zaraei so. Eur J Med Chem. 2019 Nov 1;181:111560. doi: 10.1016/j.ejmech.2019.07.063. Epub 2019 Jul 25. Eur J Med Chem. 2019. PMID: 31382118
Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS, El-Gamal R, Ullah S, Zaraei SO, Al-Rashida M, Zaib S, Pelletier J, Sévigny J, Iqbal J, El-Gamal MI. Anbar HS, et al. Among authors: zaraei so. Bioorg Chem. 2020 Nov;104:104305. doi: 10.1016/j.bioorg.2020.104305. Epub 2020 Sep 24. Bioorg Chem. 2020. PMID: 33017718
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM, Zaraei SO, El-Gamal MI, Anbar HS, Tarazi H, Zoghbor MM, Mohamood NA, Khakpour MM, Zaher DM, Omar HA, Alach NN, Shehata MK, El-Gamal R. Sbenati RM, et al. Among authors: zaraei so. Eur J Med Chem. 2021 Jan 15;210:113081. doi: 10.1016/j.ejmech.2020.113081. Epub 2020 Dec 4. Eur J Med Chem. 2021. PMID: 33310290
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors.
Ali EMH, El-Telbany RFA, Abdel-Maksoud MS, Ammar UM, Mersal KI, Zaraei SO, El-Gamal MI, Choi SI, Lee KT, Kim HK, Lee KH, Oh CH. Ali EMH, et al. Among authors: zaraei so. Eur J Med Chem. 2021 Apr 5;215:113277. doi: 10.1016/j.ejmech.2021.113277. Epub 2021 Feb 7. Eur J Med Chem. 2021. PMID: 33601311 Free article.
31 results